መነሻ › ክሮኒክ ሊምፎሳይቲክ ሉኬሚያ › North Carolina › Charlotte
በCharlotte፣ NC ለክሮኒክ ሊምፎሳይቲክ ሉኬሚያ የሚደረጉ ክሊኒካዊ ጥናቶች
ለክሮኒክ ሊምፎሳይቲክ ሉኬሚያ የሚደረጉ 9 ጥናቶች በCharlotte እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Research Site, Charlotte
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Atrium Health Levine Cancer Institute (Lci), Charlotte
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Levine Cancer Center, Charlotte
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Atrium Health Levine Cancer Institute (Lci), Charlotte
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Carolina Oncology Specialists, PA ( Site 0054), Charlotte
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Research Site, Charlotte
- Research Site, Charlotte
Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Research Site, Charlotte
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Atrium Health /ID# 267219, Charlotte
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Novant Health Presbyterian Medical Center /ID# 230201, Charlotte
በሌሎች ከተሞች ለክሮኒክ ሊምፎሳይቲክ ሉኬሚያ የሚደረጉ ጥናቶች
- Boston, MA31 ጥናቶች
- Columbus, OH28 ጥናቶች
- Durham, NC27 ጥናቶች
- Washington, DC22 ጥናቶች
- Seattle, WA20 ጥናቶች
- Rochester, MN18 ጥናቶች
- New York City, NY18 ጥናቶች
- Houston, TX17 ጥናቶች
- Baldwin Park, CA16 ጥናቶች
- Milwaukee, WI15 ጥናቶች
- Chicago, IL14 ጥናቶች
- Cincinnati, OH14 ጥናቶች
በCharlotte ውስጥ ያሉ ሌሎች ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)27 ጥናቶች
- የጡንቻ ካንሰር22 ጥናቶች
- Multiple Myeloma21 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር19 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ16 ጥናቶች
- ከባድ ሰውነት16 ጥናቶች
- ከመጠን በላይ ክብደት15 ጥናቶች
- የኮሎሬክታል ካንሰር13 ጥናቶች
- የእንቁላል ካንሰር12 ጥናቶች
- የልብ ድካም11 ጥናቶች
- Metastatic Cancer11 ጥናቶች
- የራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ10 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።